1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: IDEC-106-06, MAYO-987804, UCLA-9808026
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000530062, MAYO-LS0382, MAYO-IRB-703-04, NCT00438880
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-9804024, IDEC-106-05, NCI-G99-1614
|
|
4.
|
Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 60 and over Sponsor: NCI, Other Protocol IDs: CDR0000288830, MSKCC-02090, NCT00058422
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 to 65 Sponsor: Other Protocol IDs: 2006-1018, NCT00591630
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067697, UAB-9930, IDEC-106-98, GUMC-00095, NCI-G00-1731, NCT00005592
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: Under 22 Sponsor: NCI Protocol IDs: COG-ADVL0013, NCT00036855, ADVL0013
|